Latest News from ASCO in Action

Latest News from ASCO in Action

November 18, 2014

ASCO Chief Medical Officer Richard L. Schilsky, MD, FACP, FASCO, served on the planning committee for a workshop sponsored by the National Cancer Policy Forum of the Institute of Medicine (IOM) on “Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer.” 

November 17, 2014

ASCO called for major reform of Medicaid to ensure access to life-saving screening, treatment and prevention services for low-income Americans with cancer. 

November 17, 2014

On November 14, 2014, the U. S. Food and Drug Administration approved bevacizumab solution for intravenous infusion (Avastin®, Genentech, Inc.) in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan for the treatment of patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.